Ranodhi N Serrao
Examiner (ID: 2922, Phone: (571)272-7967 , Office: P/2444 )
Most Active Art Unit | 2444 |
Art Unit(s) | 2141, 2441, 2444 |
Total Applications | 770 |
Issued Applications | 619 |
Pending Applications | 47 |
Abandoned Applications | 100 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14566877
[patent_doc_number] => 20190211045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/353824
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353824 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | Mar 13, 2019 | Abandoned |
Array
(
[id] => 15493125
[patent_doc_number] => 20200046751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/353737
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353737
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353737 | Compounds and methods for treating neurological and cardiovascular conditions | Mar 13, 2019 | Issued |
Array
(
[id] => 16628826
[patent_doc_number] => 20210047479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => HYDROGEL COMPOSITES COMPRISING CHITOSAN AND CELLULOSE NANOFIBERS
[patent_app_type] => utility
[patent_app_number] => 16/980383
[patent_app_country] => US
[patent_app_date] => 2019-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980383 | HYDROGEL COMPOSITES COMPRISING CHITOSAN AND CELLULOSE NANOFIBERS | Mar 12, 2019 | Pending |
Array
(
[id] => 14531613
[patent_doc_number] => 20190201427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => COMPOSITIONS CONTAINING TANNIC ACIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/298804
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298804
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298804 | COMPOSITIONS CONTAINING TANNIC ACIDS AND USES THEREOF | Mar 10, 2019 | Abandoned |
Array
(
[id] => 17497580
[patent_doc_number] => 11286273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Rhamnolipid compounds and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/257255
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5103
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257255 | Rhamnolipid compounds and use thereof | Mar 7, 2019 | Issued |
Array
(
[id] => 18233196
[patent_doc_number] => 11597745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => b-modified phosphoric acid compound precursor, b-modified phosphoric acid compound, reaction inhibitor and medicine containing the same, and method for inhibiting reaction
[patent_app_type] => utility
[patent_app_number] => 16/977525
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13811
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977525
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977525 | b-modified phosphoric acid compound precursor, b-modified phosphoric acid compound, reaction inhibitor and medicine containing the same, and method for inhibiting reaction | Mar 7, 2019 | Issued |
Array
(
[id] => 16695464
[patent_doc_number] => 10946033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment
[patent_app_type] => utility
[patent_app_number] => 16/293423
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34767
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293423 | 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment | Mar 4, 2019 | Issued |
Array
(
[id] => 15432367
[patent_doc_number] => 20200030366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => INULIN FOR PREVENTING ANTIBIOTIC RESISTANT INFECTION AND PATHOGEN COLONIZATION
[patent_app_type] => utility
[patent_app_number] => 16/287716
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16287716
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/287716 | Inulin for preventing antibiotic resistant infection and pathogen colonization | Feb 26, 2019 | Issued |
Array
(
[id] => 17938450
[patent_doc_number] => 11472891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Photocrosslinkable alginic acid derivative
[patent_app_type] => utility
[patent_app_number] => 16/976027
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 72675
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 391
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976027 | Photocrosslinkable alginic acid derivative | Feb 26, 2019 | Issued |
Array
(
[id] => 14833303
[patent_doc_number] => 20190275052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND A NUCLEOS(T)IDE ANALOGUE
[patent_app_type] => utility
[patent_app_number] => 16/282481
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282481 | COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND A NUCLEOS(T)IDE ANALOGUE | Feb 21, 2019 | Abandoned |
Array
(
[id] => 16824228
[patent_doc_number] => 20210139521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => DIARYL TREHALOSE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/968075
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968075
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968075 | Diaryl trehalose compounds and uses thereof | Feb 20, 2019 | Issued |
Array
(
[id] => 16383180
[patent_doc_number] => 10808002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Method for preparing D-psicose crystal
[patent_app_type] => utility
[patent_app_number] => 16/279860
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4558
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279860 | Method for preparing D-psicose crystal | Feb 18, 2019 | Issued |
Array
(
[id] => 14497775
[patent_doc_number] => 20190192542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/277741
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16277741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/277741 | Nicotinoyl riboside compositions and methods of use | Feb 14, 2019 | Issued |
Array
(
[id] => 16450995
[patent_doc_number] => 20200360421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => COMPOSITION IN SOLID FORM FOR USE IN THE TREATMENT OF EXTRAOESOPHAGEAL SYMPTOMS OF GASTRIC REFLUX
[patent_app_type] => utility
[patent_app_number] => 16/966402
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966402
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966402 | COMPOSITION IN SOLID FORM FOR USE IN THE TREATMENT OF EXTRAOESOPHAGEAL SYMPTOMS OF GASTRIC REFLUX | Feb 12, 2019 | Pending |
Array
(
[id] => 17272897
[patent_doc_number] => 20210379095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Methods and Combination Therapy to Treat Biliary Tract Cancer
[patent_app_type] => utility
[patent_app_number] => 16/967988
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967988
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967988 | Methods and Combination Therapy to Treat Biliary Tract Cancer | Feb 11, 2019 | Pending |
Array
(
[id] => 14926401
[patent_doc_number] => 20190298838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => PROCESSES FOR PRODUCING PHARMACEUTICAL EXCIPIENTS FROM LIGNOCELLULOSIC BIOMASS, AND PHARMACEUTICAL EXCIPIENTS OBTAINED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 16/272526
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16272526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/272526 | Processes for producing pharmaceutical excipients from lignocellulosic biomass, and pharmaceutical excipients obtained therefrom | Feb 10, 2019 | Issued |
Array
(
[id] => 15813971
[patent_doc_number] => 10632142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Treatment of colitis with resistant starch
[patent_app_type] => utility
[patent_app_number] => 16/271089
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 11904
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16271089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/271089 | Treatment of colitis with resistant starch | Feb 7, 2019 | Issued |
Array
(
[id] => 16727833
[patent_doc_number] => 20210094980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE
[patent_app_type] => utility
[patent_app_number] => 16/968329
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968329 | PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE | Feb 7, 2019 | Abandoned |
Array
(
[id] => 17769365
[patent_doc_number] => 11401292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Method for producing functional crystalline sweetener
[patent_app_type] => utility
[patent_app_number] => 16/968650
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12492
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968650
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968650 | Method for producing functional crystalline sweetener | Feb 6, 2019 | Issued |
Array
(
[id] => 15345867
[patent_doc_number] => 20200010825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/268989
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/268989 | Oligosaccharides comprising an aminooxy group and conjugates thereof | Feb 5, 2019 | Issued |